JSC
NVO

Jackson Square Capital’s Novo Nordisk NVO Stock Holding History

Jackson Square Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-362
Closed -$13K – 278
2020
Q3 		$13K Sell
362
-1,212
-77% -$40.4K 0.01% 250
2020
Q2 		$52K Sell
1,574
-132
-8% -$4.21K 0.03% 156
2020
Q1 		$51K Buy
1,706
+498
+41% +$14.8K 0.04% 121
2019
Q4 		$35K Buy
+1,208
New +$33.4K 0.02% 170

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

Jackson Square Capital's NVO Position: Q4 2020 in Review

Jackson Square Capital sold out of Novo Nordisk (NVO) in Q4 2020, closing a stake of 362 shares — an estimated $13K sold.

Jackson Square Capital first reported a position in NVO in Q4 2019 and held it in 4 quarters. The position peaked at $52K in Q2 2020. 702 funds tracked by Wall St. Rank hold NVO as of Q4 2020.

  • Jackson Square Capital reported no remaining Novo Nordisk position as of Q4 2020 after selling out during the quarter.
  • Jackson Square Capital sold 362 Novo Nordisk shares in Q4 2020, an estimated $13K.
  • Jackson Square Capital first reported a position in Novo Nordisk in Q4 2019 and held it in 4 quarters.
  • Jackson Square Capital's Novo Nordisk position peaked at $52K in Q2 2020.
  • 702 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2020.

Based on Jackson Square Capital's 13F filing for Q4 2020, filed 5 Mar 2021.